Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Aug;28(2):211P–247P. doi: 10.1111/j.1365-2125.1989.tb05422.x

Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

PMCID: PMC1379912  PMID: 2775630

Full text

PDF
211P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adriaenssens P. I., Prescott L. F. High performance liquid chromatographic estimation of paracetamol metabolites in plasma. Br J Clin Pharmacol. 1978 Jul;6(1):87–88. doi: 10.1111/j.1365-2125.1978.tb01687.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Back D. J., Tjia J. F. Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship. Br J Pharmacol. 1985 May;85(1):121–126. doi: 10.1111/j.1476-5381.1985.tb08838.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bax N. D., Lennard M. S., Tucker G. T. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists. Br J Clin Pharmacol. 1981 Dec;12(6):779–784. doi: 10.1111/j.1365-2125.1981.tb01306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bernstein D. P. A new stroke volume equation for thoracic electrical bioimpedance: theory and rationale. Crit Care Med. 1986 Oct;14(10):904–909. doi: 10.1097/00003246-198610000-00017. [DOI] [PubMed] [Google Scholar]
  5. Chapleo C. B., Myers P. L., Butler R. C., Davis J. A., Doxey J. C., Higgins S. D., Myers M., Roach A. G., Smith C. F., Stillings M. R. Alpha-adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity. J Med Chem. 1984 May;27(5):570–576. doi: 10.1021/jm00371a003. [DOI] [PubMed] [Google Scholar]
  6. Chapleo C. B., Myers P. L., Butler R. C., Davis J. A., Doxey J. C., Higgins S. D., Myers M., Roach A. G., Smith C. F., Stillings M. R. Alpha-adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity. J Med Chem. 1984 May;27(5):570–576. doi: 10.1021/jm00371a003. [DOI] [PubMed] [Google Scholar]
  7. Chapleo C. B., Myers P. L., Butler R. C., Davis J. A., Doxey J. C., Higgins S. D., Myers M., Roach A. G., Smith C. F., Stillings M. R. Alpha-adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity. J Med Chem. 1984 May;27(5):570–576. doi: 10.1021/jm00371a003. [DOI] [PubMed] [Google Scholar]
  8. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  9. Cockshott I. D. Propofol ('Diprivan') pharmacokinetics and metabolism--an overview. Postgrad Med J. 1985;61 (Suppl 3):45–50. [PubMed] [Google Scholar]
  10. Coulter D. M., Edwards I. R. Cough associated with captopril and enalapril. Br Med J (Clin Res Ed) 1987 Jun 13;294(6586):1521–1523. doi: 10.1136/bmj.294.6586.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Croog S. H., Levine S., Testa M. A., Brown B., Bulpitt C. J., Jenkins C. D., Klerman G. L., Williams G. H. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986 Jun 26;314(26):1657–1664. doi: 10.1056/NEJM198606263142602. [DOI] [PubMed] [Google Scholar]
  12. Currie D., Lewis R. V., McDevitt D. G., Nicholson A. N., Wright N. A. Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood. Br J Clin Pharmacol. 1988 Aug;26(2):121–128. doi: 10.1111/j.1365-2125.1988.tb03378.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Danhof M., Groot-van der Vis E., Breiner D. D. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man. Pharmacology. 1979;18(4):210–223. doi: 10.1159/000137254. [DOI] [PubMed] [Google Scholar]
  14. Denniston J. C., Maher J. T., Reeves J. T., Cruz J. C., Cymerman A., Grover R. F. Measurement of cardiac output by electrical impedance at rest and during exercise. J Appl Physiol. 1976 Jan;40(1):91–95. doi: 10.1152/jappl.1976.40.1.91. [DOI] [PubMed] [Google Scholar]
  15. Dundee J. W., Chestnutt W. N., Ghaly R. G., Lynas A. G. Traditional Chinese acupuncture: a potentially useful antiemetic? Br Med J (Clin Res Ed) 1986 Sep 6;293(6547):583–584. doi: 10.1136/bmj.293.6547.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Evans D. A., Harmer D., Downham D. Y., Whibley E. J., Idle J. R., Ritchie J., Smith R. L. The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet. 1983 Oct;20(5):321–329. doi: 10.1136/jmg.20.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Evans D. A., Mahgoub A., Sloan T. P., Idle J. R., Smith R. L. A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet. 1980 Apr;17(2):102–105. doi: 10.1136/jmg.17.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fedder I. L., Vlasses P. H., Mojaverian P., Rocci M. L., Jr, Rotmensch H. H., Swanson B. N., Ferguson R. K. Relationship of morphine-induced miosis to plasma concentration in normal subjects. J Pharm Sci. 1984 Oct;73(10):1496–1497. doi: 10.1002/jps.2600731047. [DOI] [PubMed] [Google Scholar]
  19. Fitzharris P., McLean A. E., Sparks R. G., Weatherley B. C., White R. D., Wootton R. The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve. Br J Clin Pharmacol. 1985 Apr;19(4):471–481. doi: 10.1111/j.1365-2125.1985.tb02672.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gerson W. T., Fine D. G., Spielberg S. P., Sensenbrenner L. L. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro. Blood. 1983 May;61(5):889–893. [PubMed] [Google Scholar]
  21. Ghodse A. H., Bewley T. H., Kearney M. K., Smith S. E. Mydriatic response to topical naloxone in opiate abusers. Br J Psychiatry. 1986 Jan;148:44–46. doi: 10.1192/bjp.148.1.44. [DOI] [PubMed] [Google Scholar]
  22. Ginman R. F., Colliss J. S. Modified liquid-chromatographic method for creatinine determinations. Clin Chem. 1985 Feb;31(2):331–332. [PubMed] [Google Scholar]
  23. Greaves M., Marks R., Robertson I. Receptors for histamine in human skin blood vessels: a review. Br J Dermatol. 1977 Aug;97(2):225–228. doi: 10.1111/j.1365-2133.1977.tb15071.x. [DOI] [PubMed] [Google Scholar]
  24. Harder S., Staib A. H., Beer C., Papenburg A., Stille W., Shah P. M. 4-quinolones inhibit biotransformation of caffeine. Eur J Clin Pharmacol. 1988;35(6):651–656. doi: 10.1007/BF00637602. [DOI] [PubMed] [Google Scholar]
  25. Heavey D. J., Ind P. W., Miyatake A., Brown M. J., Macdermot J., Dollery C. T. Histamine released locally after intradermal antigen challenge in man. Br J Clin Pharmacol. 1984 Dec;18(6):915–919. doi: 10.1111/j.1365-2125.1984.tb02564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Henocq E., Vargaftig B. B. Skin eosinophilia in atopic patients. J Allergy Clin Immunol. 1988 Apr;81(4):691–695. doi: 10.1016/0091-6749(88)91040-8. [DOI] [PubMed] [Google Scholar]
  27. Hirayama H., Kasuya Y., Suga T. High-performance liquid chromatographic determination of bromazepam in human plasma. J Chromatogr. 1983 Oct 14;277:414–418. doi: 10.1016/s0378-4347(00)84868-9. [DOI] [PubMed] [Google Scholar]
  28. Hogg K. J., Hornung R. S., Howie C. A., Hillis W. S. Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action. Br J Clin Pharmacol. 1987 Oct;24(4):435–442. doi: 10.1111/j.1365-2125.1987.tb03195.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hong C. Y., Chaput de Saintonge D. M., Turner P. The inhibitory action of procaine, (+)-propranolol and (+/-)-propranolol on human sperm motility: antagonism by caffeine. Br J Clin Pharmacol. 1981 Nov;12(5):751–753. doi: 10.1111/j.1365-2125.1981.tb01301.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hottinger C. F., Meindl J. D. Blood flow measurement using the attenuation-compensated volume flowmeter. Ultrason Imaging. 1979 Jan;1(1):1–15. doi: 10.1177/016173467900100101. [DOI] [PubMed] [Google Scholar]
  31. Kenna J. G., Neuberger J., Williams R. Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis. Hepatology. 1988 Nov-Dec;8(6):1635–1641. doi: 10.1002/hep.1840080627. [DOI] [PubMed] [Google Scholar]
  32. Kenna J. G., Neuberger J., Williams R. Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis. J Pharmacol Exp Ther. 1987 Aug;242(2):733–740. [PubMed] [Google Scholar]
  33. Kenna J. G., Satoh H., Christ D. D., Pohl L. R. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Pharmacol Exp Ther. 1988 Jun;245(3):1103–1109. [PubMed] [Google Scholar]
  34. Khayat D., Lokiec F., Bizzari J. P., Weil M., Meeus L., Sellami M., Rouesse J., Banzet P., Jacquillat C. Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule. Cancer Res. 1987 Dec 15;47(24 Pt 1):6782–6785. [PubMed] [Google Scholar]
  35. Kitteringham N. R., Lambert C., Maggs J. L., Colbert J., Park B. K. A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes. Br J Clin Pharmacol. 1988 Jul;26(1):13–21. doi: 10.1111/j.1365-2125.1988.tb03358.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lee H. K., Wang S. C. Mechanism of morphine-induced miosis in the dog. J Pharmacol Exp Ther. 1975 Feb;192(2):415–431. [PubMed] [Google Scholar]
  37. McBride P., Bradley D., Kaliner M. Evaluation of a radioimmunoassay for histamine measurement in biologic fluids. J Allergy Clin Immunol. 1988 Oct;82(4):638–646. doi: 10.1016/0091-6749(88)90977-3. [DOI] [PubMed] [Google Scholar]
  38. Milsom I., Sivertsson R., Biber B., Olsson T. Measurement of stroke volume with impedance cardiography. Clin Physiol. 1982 Oct;2(5):409–417. doi: 10.1111/j.1475-097x.1982.tb00047.x. [DOI] [PubMed] [Google Scholar]
  39. Mirahmadi M. K., Byrne C., Barton C., Penera N., Gordon S., Vaziri N. D. Prediction of creatinine clearance from serum creatinine in spinal cord injury patients. Paraplegia. 1983 Feb;21(1):23–29. doi: 10.1038/sc.1983.4. [DOI] [PubMed] [Google Scholar]
  40. Mitchell S. C., Waring R. H., Haley C. S., Idle J. R., Smith R. L. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmacol. 1984 Oct;18(4):507–521. doi: 10.1111/j.1365-2125.1984.tb02498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nicholson A. N., Wright N. A., Zetlein M. B., Currie D., McDevitt D. G. Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway. Br J Clin Pharmacol. 1988 Aug;26(2):129–141. doi: 10.1111/j.1365-2125.1988.tb03379.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Nomof N., Elliott H. W., Parker K. D. The local effect of morphine, nalorphine, and codeine on the diameter of the pupil of the eye. Clin Pharmacol Ther. 1968 May-Jun;9(3):358–364. doi: 10.1002/cpt196893358. [DOI] [PubMed] [Google Scholar]
  43. Ochs H. R., Greenblatt D. J., Verburg-Ochs B. Propranolol interactions with diazepam, lorazepam, and alprazolam. Clin Pharmacol Ther. 1984 Oct;36(4):451–455. doi: 10.1038/clpt.1984.203. [DOI] [PubMed] [Google Scholar]
  44. Parker P. J., Stabel S., Waterfield M. D. Purification to homogeneity of protein kinase C from bovine brain--identity with the phorbol ester receptor. EMBO J. 1984 May;3(5):953–959. doi: 10.1002/j.1460-2075.1984.tb01913.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pearson R. M., Ridgway E. J., Johnston A., Vadukul J. Concentration of D-propranolol in cervicovaginal mucus. Lancet. 1984 Dec 22;2(8417-8418):1480–1480. doi: 10.1016/s0140-6736(84)91684-2. [DOI] [PubMed] [Google Scholar]
  46. Peterson R. N., Freund M. Effects of (H + ), (Na + ), (K + ) and certain membrane-active drugs on glycolysis, motility, and ATP synthesis by human spermatozoa. Biol Reprod. 1973 Apr;8(3):350–357. doi: 10.1093/biolreprod/8.3.350. [DOI] [PubMed] [Google Scholar]
  47. Pong S. S., DeHaven R. N. Characterization of a leukotriene D4 receptor in guinea pig lung. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7415–7419. doi: 10.1073/pnas.80.24.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Purba H. S., Maggs J. L., Orme M. L., Back D. J., Park B. K. The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol. 1987 Apr;23(4):447–453. doi: 10.1111/j.1365-2125.1987.tb03074.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Riley R. J., Maggs J. L., Lambert C., Kitteringham N. R., Park B. K. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br J Clin Pharmacol. 1988 Nov;26(5):577–588. doi: 10.1111/j.1365-2125.1988.tb05298.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sciberras D. G., Goldenberg M. M., Bolognese J. A., James I., Baber N. S. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. Br J Clin Pharmacol. 1987 Dec;24(6):753–761. doi: 10.1111/j.1365-2125.1987.tb03242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Siersbaek-Nielsen K., Hansen J. M., Kampmann J., Kristensen M. Rapid evaluation of creatinine clearance. Lancet. 1971 May 29;1(7709):1133–1134. doi: 10.1016/s0140-6736(71)91873-3. [DOI] [PubMed] [Google Scholar]
  52. Skidmore R., Wells P. N. Measurement of cardiac output. Lancet. 1988 Oct 8;2(8615):854–854. doi: 10.1016/s0140-6736(88)92820-6. [DOI] [PubMed] [Google Scholar]
  53. Spielberg S. P., Gordon G. B., Blake D. A., Goldstein D. A., Herlong H. F. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med. 1981 Sep 24;305(13):722–727. doi: 10.1056/NEJM198109243051302. [DOI] [PubMed] [Google Scholar]
  54. Starkova N. T., Egart F. M., Aleksandrov K. A. Nekotorye osobennosti polovogo razvitiia u bol'nykh s dientsefal'nym sindromom pubertal'no-iunosheskogo perioda. Akush Ginekol (Mosk) 1974 Aug;0(8):6–10. [PubMed] [Google Scholar]
  55. Takaori K., Itoh S., Kanayama Y., Takeda T. Protein kinase C activity in platelets from spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto rats (WKY). Biochem Biophys Res Commun. 1986 Dec 15;141(2):769–773. doi: 10.1016/s0006-291x(86)80239-x. [DOI] [PubMed] [Google Scholar]
  56. Teo K. K., Hetherington M. D., Haennel R. G., Greenwood P. V., Rossall R. E., Kappagoda T. Cardiac output measured by impedance cardiography during maximal exercise tests. Cardiovasc Res. 1985 Dec;19(12):737–743. doi: 10.1093/cvr/19.12.737. [DOI] [PubMed] [Google Scholar]
  57. Teunissen M. W., Meerburg-van der Torren J. E., Vermeulen N. P., Breimer D. D. Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine. J Chromatogr. 1983 Dec 9;278(2):367–378. [PubMed] [Google Scholar]
  58. Town G. I., Hallwright G. P., Maling T. J., O'Donnell T. V. Angiotensin converting enzyme inhibitors and cough. N Z Med J. 1987 Mar 25;100(820):161–163. [PubMed] [Google Scholar]
  59. Tress K. H., El-Sobky A. A. Pupil responses to intravenous heroin (diamorphine) in dependent and non-dependent humans. Br J Clin Pharmacol. 1979 Feb;7(2):213–217. doi: 10.1111/j.1365-2125.1979.tb00924.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Turtle M. J., Cullen P., Prys-Roberts C., Coates D., Monk C. R., Faroqui M. H. Dose requirements of propofol by infusion during nitrous oxide anaesthesia in man. II: Patients premedicated with lorazepam. Br J Anaesth. 1987 Mar;59(3):283–287. doi: 10.1093/bja/59.3.283. [DOI] [PubMed] [Google Scholar]
  61. Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A. L., Davis M., Williams R. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980 Jul 10;303(2):66–71. doi: 10.1056/NEJM198007103030202. [DOI] [PubMed] [Google Scholar]
  62. Walley T. J., Heagerty A. M., Woods K. L., Bing R. F., Pohl J. E., Barnett D. B. Acute inotropic effects of intravenous nifedipine and its vehicle compared with saline: a double-blind study of systolic time intervals in normal subjects. Br J Clin Pharmacol. 1988 Feb;25(2):187–193. doi: 10.1111/j.1365-2125.1988.tb03290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Whelpton R., Watkins G., Curry S. H. Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status. Clin Chem. 1981 Nov;27(11):1911–1914. [PubMed] [Google Scholar]
  64. Wijnands W. J., Vree T. B., van Herwaarden C. L. The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol. 1986 Dec;22(6):677–683. doi: 10.1111/j.1365-2125.1986.tb02957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Williams P. E., Harding S. M. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food. J Antimicrob Chemother. 1984 Feb;13(2):191–196. doi: 10.1093/jac/13.2.191. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES